Transaction Details

Footnotes

Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. | Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power. | Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units. | Includes 62 shares of common stock acquired on March 4, 2026 under the United Therapeutics Employee Stock Purchase Plan. | Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023.